Type 2 Diabetes, Obesity and Cortisol Excess
Recruiting now
Conditions studied: Diabetes Mellitus, Type 2, Obesity, Cortisol; Hypersecretion
In brief
The present observational cross-sectional study is aimed to assess: the hidden hypercortisolism (HidHyCo) prevalence in a sample of Type 2 diabetes (T2D) patients and the clinical characteristics more frequently associated with the HidHyCo presence and the HidHyCo prevalence in an adequate sample of obese patients without T2D and the clinical characteristics more frequently associated with the HidHyCo presence.
Key facts
- Study ID
- NCT05759637
- Run by
- Istituto Auxologico Italiano
- People needed
- 3200
- Starts
- 2022-05-06
- Expected to finish
- 2025-12-06
- Last updated by the study team
- 2025-03-24
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patients with T2D and Obesity
You may not qualify if…
- pregnancy/breast feeding,
- sleep apnea,
- prepuberal onset of hypertension, hormonal hypersecreting adrenal mass,
- symptoms of hypercortisolism;
- already known secondary hypertension;
- conditions associated with increased hypothalamic-pituitary-adrenal (HPA) axis activity, -severe autoimmune/rheumatologic and hematologic diseases, alcoholism, kidney disease (glomerular filtration rate <60)
- drugs influencing the HPA axis activity. For inclusion in Group 2 the presence of T2D will be an exclusion criteria
Where it is running
- Istituto Auxologico Italiano — Milan, Italy (enrolling)
- Niguarda Hospital — Milan, Italy (enrolling)
- Campus Bio-Medico University — Roma, Italy (enrolling)
- University of Siena — Siena, Italy (enrolling)
- Azienda Ospedaliero Universitaria, Santa Maria della Misericordia di Udine — Udine, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.